Intellipharmaceuticals International Inc.
IPCI
IPCI was delisted on the 20th of March, 2019.
21 hedge funds and large institutions have $4.9M invested in Intellipharmaceuticals International Inc. in 2014 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 4 closing their positions.
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
5% more funds holding
Funds holding: 20 → 21 (+1)
18% less capital invested
Capital invested by funds: $5.94M → $4.9M (-$1.04M)
65% less call options, than puts
Call options by funds: $127K | Put options by funds: $367K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$558K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$107K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$55.8K |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$27K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$13.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$96K |
| 2 |
ARTA
A.R.T. Advisors
New York
|
-$53K |
| 3 |
Jane Street
New York
|
-$36K |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$36K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$24.4K |
IPCI Hedge Fund Activity: Q4 2014 in Review
21 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Intellipharmaceuticals International Inc. (IPCI) for Q4 2014, worth a combined $4.9M — down 18% from $5.94M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new IPCI positions and 4 closed out — a net gain of 2 holders — while 5 added to existing stakes and 4 trimmed.
The largest buyer was DAFNA Capital Management, adding an estimated $558K. The largest seller was Morgan Stanley, cutting an estimated $96K.
- 21 institutional investors held Intellipharmaceuticals International Inc. (IPCI) as of Q4 2014, up from 20 in Q3 2014.
- Funds reported $4.9M of Intellipharmaceuticals International Inc. stock for Q4 2014, down 18% quarter-over-quarter.
- 6 funds opened new Intellipharmaceuticals International Inc. positions in Q4 2014 and 4 closed out, a net change of +2 holders.
- The largest Intellipharmaceuticals International Inc. buyer in Q4 2014 was DAFNA Capital Management, an estimated $558K added.
- The largest Intellipharmaceuticals International Inc. seller in Q4 2014 was Morgan Stanley, an estimated $96K sold.
Based on aggregated 13F filings for Q4 2014.